Immunostimulants Market to Surpass US$ 197.6 Bn by 2032, Amid Increasing Prevalence of Autoimmune Disorders - Future Market Insights, Inc.

·7 min read
Future Market Insights Global and Consulting Pvt. Ltd.
Future Market Insights Global and Consulting Pvt. Ltd.

The immunostimulants market in Germany is expected to grow at a 6.4% CAGR over the next ten years. The oncology segment will account for 34.7% of the total market share by 2032, which is a significant increase from its current level and projected growth rate over this time period

NEWARK, Del, July 07, 2022 (GLOBE NEWSWIRE) -- Immunostimulants are drugs that stimulate the immune system by accelerating the activity of immune cells, tissues, and organs and also help the body to fight against sepsis and diseases.

As per Future Market Insights’ latest industry analysis, the global immunostimulants market was valued at around US$ 102.2 Bn in 2021 and is anticipated to exhibit a CAGR of close to 6.2% over the forecast period (2022-2032). Against this backdrop, the market size is projected to reach US$ 108.2 Bn in 2022.

Request a Sample of this Report@

Growing prevalence of autoimmune diseases is fueling the development of immunostimulants. Around 4% of the world’s population is affected by different autoimmune diseases, which also include multiple sclerosis and rheumatoid arthritis. In the U.S., autoimmune diseases represent the third most common chronic disorder.

Further, demand for immunostimulants in countries such as India and China is expected to increase at a considerable pace. Developing economies are refining their healthcare framework, owing to increasing accessibility to resources, and increasing efforts by manufacturers to gain drug approvals for international retail.

For instance, in November 2021, PharmaEssentia Corporation, a company based in Taiwan, announced that the U.S. Food and Drug Administration (FDA) has approved BESREMi, long-acting interferon for the treatment of adults with polycythemia vera.

“Rising awareness regarding immunostimulants therapy for chronic diseases across emerging economies, along with increasing investments in the pharmaceutical and healthcare sectors will fuel the growth in the market over the forecast period,” says an FMI analyst.

Download PDF Brochure @

Key Takeaways:

  • Based on product type, demand for vaccines is expected to increase at a 6.4% CAGR over the forecast period.

  • In terms of application, the oncology segment will account for 34.7% of the total market share by 2032.

  • By end user, hospital pharmacies held 34.3% of the total market share in 2021 and the trend is expected to continue over the forecast period.

  • The U.S. accounted for 92.85 of the North America immunostimulants market in 2021.

  • Sales in the Germany immunostimulants market are forecast to increase at a 6.4% CAGR over the assessment period.

  • Demand for immunostimulants in Japan will grow at a 6% CAGR over the forecast period.

Competition Landscape

Leading players operating in the global immunostimulants market are investing in acquisitions and collaborations to expand their global presence. They are also investing in research and development to improve their product portfolios. Key Players - F. Hoffmann-La Roche Ltd, Merck KGaA, Bayer AG, Biogen Idec, GenSci, Sinovac, BioLegend, Invitrogen, OriGene, Biorbyt, Qilu Pharmaceutical, Shijiazhuang Pharmaceutical, Amgen Inc, Johnson & Johnson, Kyowa Hakko Kirin, Bristol-Myers Squibb, Zydus Cadila, Novartis AG, Pfizer Inc, Amega Biotech, 3Sbio, Biosidus, Nanogen

For instance:

  • In August 2021, Bayer AG acquired Vividion Therapeutics to strengthen its drug discovery platform to meet the high unmet medical needs for immune-related diseases and for oncology.

  • In August 2020, Bristol Myers Squibb collaborated with Dragonfly Therapeutics and announced an exclusive global license for Dragonfly’s IL-12 investigational immunotherapy program.

Speak to our Research Expert@

Want more insights?

Future Market Insights brings a comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2032. The global immunostimulants market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on the immunostimulants market segment based on by product type – (colony-stimulating factors, interferons, interleukins, and vaccines), by application- (oncology, respiratory, chronic, and autoimmune disorders, and others), by end-user (hospital pharmacies, retail pharmacies, specialty clinics, and online pharmacies), across seven major regions.

Key Market Segments Covered in Immunostimulants Industry Research

By Product:

  • Colony Stimulating Factors

  • Interferons

  • Interleukins

  • Vaccines

By Application:

  • Oncology

  • Respiratory

  • Chronic & Autoimmune Disorders

  • Others

By End-User:

  • Hospital Pharmacies

  • Retail Pharmacies

  • Specialty Clinics

  • Online Pharmacies

About Healthcare Division at Future Market Insights
Future Market Insights facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you in devising innovation-driven trajectories for your business. Know more about our sector coverage here.

Buy Now@

Table of Content
1. Executive Summary

  1.1. Global Market Outlook

  1.2. Demand Side Trends

  1.3. Supply-Side Trends

  1.4. Analysis and Recommendations

2. Market Overview

  2.1. Market Coverage / Taxonomy

  2.2. Market Definition / Scope / Limitations

  2.3. Inclusions and Exclusions

3. Key Market Trends

  3.1. Key Trends Impacting the Market

  3.2. Product Innovation / Development Trends

4. Key Success Factors

  4.1. Product Adoption/Usage Analysis

  4.2. Pipeline Assessment

  4.3. Regulatory Landscape

  4.4. Reimbursement Outlook

  4.5. Key Marketing & Promotional Strategies Adopted By Companies

  4.6. PESTLE Analysis

  4.7. Porters Analysis

Get detailed TOC @

Have a Look at Related Research Reports of Healthcare

Immunochemistry Analyzer Market Size : The immunochemistry analyzer market is expected to register a CAGR of 16% during the forecast period, up from US$ 14.2 Bn in 2021, to reach a valuation of US$ 72.69 Bn by 2032.

Immunochemistry Products Market Forecast : The immunochemistry products market is anticipated to record a CAGR of 7.25% during the forecast period, up from US$ 2.08 Bn in 2021 to reach a valuation of US$ 4.5 Bn by 2032.

Interferons Market Value :  The global interferons market is set to reach a valuation of US$ 9.4 Bn in 2022, and further expand at a CAGR of 3.9% in the forecast period from 2022 to 2032

Intravascular Imaging Market Sales : The intravascular imaging market is projected to register a CAGR of 5.3% during the forecast period, up from US$ 367.48 Mn in 2022 to reach a valuation of US$ 615.91 Mn by 2032.

Bacterial Diagnostics in Aquaculture Market Analysis : The bacterial diagnostics in aquaculture market is projected to register a CAGR of 7% during the forecast period, up from US$ 3.5 Bn in 2021, to reach a valuation of US$ 8.4 Bn by 2032.

Dynamic Spinal Tethering Systems Market Volume : The dynamic spinal tethering system market is likely to record a CAGR of 10% during the forecast period, up from US$ 59.7 Mn in 2022 to reach a valuation of US$ 154.85 Mn by 2032.

Bleeding Control Kit Market Growth : The global bleeding control kit market size is expected to be valued at US$ 7.6 Billion in 2032 and exhibit growth at a CAGR of 2.9% in the forecast period from 2022 to 2032.

Custom Hearing Aids Market Demand : The global custom hearing aids market size is expected to reach US$ 9.5 Billion in 2022 and US$ 12.3 Billion in 2032.

3D Surgical Microscope Systems Market Outlook : The global 3D surgical microscope systems garnered a market value of US$ 1109.9 Million in 2022 and is expected to accumulate a market value of US$ 2905.1 Million by registering a CAGR of 10.1% in the forecast period.

Diabetes Care Devices Market Trends : The global Diabetes care devices market is advancing at an average rate to record a CAGR of 6.3% from 2022-2032.

About Us

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.


Future Market Insights Inc.  
Christiana Corporate, 200 Continental Drive, 
Suite 401, Newark, Delaware - 19713, USA  
T: +1-845-579-5705  
For Sales Enquiries:
Browse latest Market Reports:
LinkedIn| Twitter| Blogs

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting